Viridans-Group Streptococci
Revision as of 02:14, 3 April 2014 by Rossdonaldson1 (talk | contribs) (Rossdonaldson1 moved page Viridans strep to Streptococci Viridans)
Background
Antibiotic Sensitivities[1]
Organisms | ' | Viridans strep |
Penicillins | Penicillin G | +/- |
Penicillin V | +/- | |
Anti-Staphylocccal Penicillins | Methicillin | +/- |
Nafcillin/Oxacillin | +/- | |
Cloxacillin/Diclox. | +/- | |
Amino-Penicillins | AMP/Amox | +/- |
Amox/Clav | +/- | |
AMP-Sulb | +/- | |
Anti-Pseudomonal Penicillins | Ticarcillin | +/- |
Ticar-Clav | +/- | |
Pip-Taxo | +/- | |
Carbapenems | Piperacillin | +/- |
Doripenem | + | |
Ertapenem | + | |
Imipenem | + | |
Meropenem | + | |
Aztreonam | 0 | |
Fluroquinolones | Ciprofloxacin | 0 |
Ofloxacin | 0 | |
Pefloxacin | ||
Levofloxacin | + | |
Moxifloxacin | + | |
Gemifloxacin | + | |
Gatifloxacin | + | |
1st G Cephalosporin | Cefazolin | + |
2nd G. Cephalosporin | Cefotetan | + |
Cefoxitin | + | |
Cefuroxime | + | |
3rd/4th G. Cephalosporin | CefoTAXime | + |
Cefizoxime | + | |
CefTRIAXone | + | |
Ceftobiprole | + | |
Ceftaroline | + | |
CefTAZidime | +/- | |
Cefepime | + | |
Oral 1st G. Cephalosporin | Cefadroxil | + |
Cephalexin | + | |
Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | + |
Cefproxil | 0 | |
Cefuroxime axetil | + | |
Oral 3rd G. Cephalosporin | Cefixime | + |
Ceftibuten | 0 | |
Cefpodox/Cefdinir/Cefditoren | + | |
Aminoglycosides | Gentamicin | |
Tobramycin | ||
Amikacin | ||
Chloramphenicol | ||
Clindamycin | ||
Macrolides | Erythromycin | |
Azithromycin | ||
Clarithromycin | ||
Ketolide | Telithromycin | |
Tetracyclines | Doxycycline | |
Minocycline | ||
Glycylcycline | Tigecycline | |
Glyco/Lipoclycopeptides | Vancomycin | |
Teicoplanin | ||
Telavancin | ||
Fusidic Acid | ||
Trimethoprim | ||
TMP-SMX | ||
Urinary Agents | Nitrofurantoin | |
Fosfomycin | ||
Other | Rifampin | |
Metronidazole | ||
Quinupristin dalfoppristin | ||
Linezolid | ||
Daptomycin | ||
Colistimethate |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010